The sample of choice for detecting Middle East respiratory syndrome coronavirus in asymptomatic dromedary camels using real-time reverse-transcription polymerase chain reaction

The newly identified Middle East respiratory syndrome coronavirus (MERS-CoV), which causes severe respiratory disease, particularly in people with comorbidities, requires further investigation. Studies in Qatar and elsewhere have provided evidence that dromedary camels are a reservoir for the virus, but the exact modes of transmission of MERS-CoV to humans remain unclear. In February 2014, an assessment was made of the suitability and sensitivity of different types of sample for the detection of MERS-CoV by real-time reverse-transcription polymerase chain reaction (RT-PCR) for three gene targets: UpE (upstream of the E gene), the N (nucleocapsid) gene and open reading frame (ORF) 1a. Fifty-three animals presented for slaughter were sampled. A high percentage of the sampled camels (79% [95% confidence interval 66.9-91.5%, standard error 0.0625]; 42 out of 53) were shown to be shedding MERS-CoV at the time of slaughter, yet all the animals were apparently healthy. Among the virus-positive animals, nasal swabs were most often positive (97.6%). Oral swabs were the second most frequently positive (35.7%), followed by rectal swabs (28.5%). In addition, the highest viral load, expressed as a cycle threshold (Ct) value of 11.27, was obtained from a nasal swab. These findings lead to the conclusion that nasal swabs are the candidate sample of choice for detecting MERS-CoV using RT-PCR technology in apparently healthy camels

Isolation of MERS coronavirus from dromedary camel, Qatar, 2014

We obtained the full genome of Middle East respiratory syndrome coronavirus (MERS-CoV) from a camel in Qatar. This virus is highly similar to the human England/ Qatar 1 virus isolated in 2012. The MERS-CoV from the camel efficiently replicated in human cells, providing further evidence for the zoonotic potential of MERS-CoV from camels

Clinical, hematological, and biochemical studies on hypozincemia in neonatal calves in Egypt

Background and Aim: Zinc has a wide spectrum of biological activities and its deficiency has been related to various dysfunctions. This study aimed to clarify the clinical, hematological, and biochemical changes in Holstein dairy calves with naturally occurring hypozincemia before and after treatment. Materials and Methods: This study was carried out on 25 Holstein dairy calves <1 month of age in the El-Salhya Dairy Farm, Al-Sharqiya Province, Egypt. Calves were born from apparent healthy dams without any clinical signs of zinc deficiency. They were divided into two groups. The first group (G1) included five clinically healthy calves that were used as controls. The second group (G2) included 20 calves suffering from alopecia and skin lesions. The diseased calves were then treated by oral administration of zinc oxide at the rate of 80 mg/day for 10 successive days and then 20 mg/week for 2 weeks (G3). A total of 90 samples, whole blood and serum samples were collected during the study across all groups. Whole blood was evaluated for complete blood count and serum was used to estimate total protein, albumin, globulin, zinc, calcium, magnesium, phosphorus, and the activity of alkaline phosphatase (ALP) and aspartate aminotransferase. Results: The diseased calves had macrocytic normochromic anemia. Total leukocytes, neutrophils, and lymphocytes were significantly reduced in the diseased calves than in the control and treated groups. Biochemical analysis of serum revealed a highly significant decrease in the globulin, zinc, and calcium concentrations in the diseased calves than in the control and treated groups. ALP activity was significantly lower in the diseased and treated calves than in control. There were no differences in any other parameters between the groups. Conclusion: Zinc deficiency naturally occurring in calves caused clinical, hematological, and biochemical alterations such as alopecia, skin abnormalities, and macrocytic normochromic anemia. In addition, zinc deficiency altered the cell-mediated immunity as indicated by leukopenia and lymphopenia. These alterations were improved by oral administration of zinc oxide

Epidemiological investigations on microbial infection and crystals causing feline lower urinary tract disease in tomcats in Ismailia, Egypt

Background: Feline lower urinary tract disease (FLUTD) is a common disorder associated with the dysfunction of the urinary bladder or urethra in tomcats.Aim: A prospective study was carried out on the point prevalence and odds ratio (OR) of the FLUTD in Shirazi and Baladi tomcats at Ismailia Governorate, Egypt, recording the prominent clinical manifestation and identifying the antibiogram, virulence, and antimicrobial resistance genes of the causative microorganisms.Methods: A total number of 420 tomcats admitted to the veterinary clinics of Ismailia during the period June 2020 to May 2021 were examined for FLUTD. A total of 1,260 urine samples were collected and analyzed.Results: Hematuria, dysuria, and pollakiuria were the most evident signs recorded in a total of 120 tomcats diagnosed with FLUTD. The diagnosed cases of FLUTD were associated with causes like crystals (35.83%), pyogenic microorganisms (19.16%), and mixed cases (45.00%). The prevalence revealed highly significant (p &lt; 0.01) increases in the cases caused by Escherichia coli, E. coli mixed cases, and calcium oxalate at &gt;4 years; Staphylococcus aureus at ≤ 2 years; amorphous urate and phosphate at 2–4 and &gt;4 years in Shirazi and ≤2 years in Baladi; triple phosphate at ≤2 years in Shirazi and &gt;4 years in Baladi; and S. aureus mixed cases at ≤2 years. The OR of FLUTD revealed higher odds of associations with E. coli, E. coli mixed cases, S. aureus, amorphous urate, and triple phosphate, as well as lower odds with S. aureus, calcium oxalate, amorphous phosphate, and S. aureus mixed cases. Isolated E. coli revealed higher resistance to amoxicillin (AMX, 83.4%), ceftriaxone (83.4%), ceftazidime (CAZ, 75.0%), and cefoxitin (FOX, 50.0%), and S. aureus to oxacillin (100%), FOX (100%), AMX (85.8%), CAZ (76.2%), and FOX (50.0%). S. aureusdetected virulence genes were mecA, coa, spa, and tetK, and E. coli were fimH, iss, iutA, papC, blaTEM, blaCTX-M, and tetA. About 100% of E. coli and 76.1% of S. aureus isolates exhibited multidrug resistance.Conclusion: FLUTD in tomcats is associated with higher odds in E. coli, E. coli mixed cases, and triple phosphate at older ages (&gt;4 years) with high antimicrobial resistance in the microbial isolates contributing to the disease

Oxoketene Dithiols: Synthesis of Some Heterocycles as Antimicrobials Utilizing Shrimp Chitin as a Natural Catalyst

<div><p>GRAPHICAL ABSTRACT</p><p></p></div

Preparation and Characterization of Blank and Nerolidol-Loaded Chitosan&ndash;Alginate Nanoparticles

Recently, there has been a growing interest in using natural products as treatment alternatives in several diseases. Nerolidol is a natural product which has been shown to have protective effects in several conditions. The low water solubility of nerolidol and many other natural products limits their delivery to the body. In this research, a drug delivery system composed of alginate and chitosan was fabricated and loaded with nerolidol to enhance its water solubility. The chitosan&ndash;alginate nanoparticles were fabricated using a new method including the tween 80 pre-gelation, followed by poly-ionic crosslinking between chitosan negative and alginate positive groups. Several characterization techniques were used to validate the fabricated nanoparticles. The molecular interactions between the chitosan, alginate, and nerolidol molecules were confirmed using the Fourier transform infrared spectroscopy. The ultraviolet spectroscopy showed an absorbance peak of the blank nanoparticles at 200 nm and for the pure nerolidol at 280 nm. Using both scanning and transmission electron microscopy, the nanoparticles were found to be spherical in shape with an average size of 12 nm and 35 nm for the blank chitosan&ndash;alginate nanoparticles and the nerolidol-loaded chitosan&ndash;alginate nanoparticles, respectively. The nanoparticles were also shown to have a loading capacity of 51.7% and an encapsulation efficiency of 87%. A controlled release profile of the loaded drug for up to 28 h using an in vitro model was also observed, which is more efficient than the free form of nerolidol. In conclusion, chitosan&ndash;alginate nanoparticles and nerolidol loaded chitosan&ndash;alginate nanoparticles were successfully fabricated and characterized to show potential encapsulation and delivery using an in vitro model